Literature DB >> 22723396

Comment on "Seroevidence for H5N1 influenza infections in humans: meta-analysis".

Maria D Van Kerkhove1, Steven Riley, Marc Lipsitch, Yi Guan, Arnold S Monto, Robert G Webster, Maria Zambon, Angus Nicoll, J S Malik Peiris, Neil M Ferguson.   

Abstract

A better understanding of the severity of H5N1 in humans is needed. Wang et al. (Brevia, 23 March 2012, p. 1463; published online 23 February 2012) overinterpret the results of seroprevalence studies and take too little account of underlying uncertainties. Although the true risk of death from H5N1 infection will likely be lower than the 60% of reported laboratory-confirmed cases, there is little evidence of millions of missed infections.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22723396     DOI： 10.1126/science.1221434

Source DB:  PubMed          Journal:  Science        ISSN： 0036-8075            Impact factor:   47.728


  24 in total

1.  Assessment of serosurveys for H5N1.

Authors:  Eric S Toner; Amesh A Adalja; Jennifer B Nuzzo; Thomas V Inglesby; Donald A Henderson; Donald S Burke
Journal:  Clin Infect Dis       Date:  2013-02-05       Impact factor: 9.079

2.  Does exposure to poultry and wild fowl confer immunity to H5N1?

Authors:  Yang Wan; Shaman Jeffrey
Journal:  Chin Med J (Engl)       Date:  2014       Impact factor: 2.628

3.  Differences in the Epidemiology of Human Cases of Avian Influenza A(H7N9) and A(H5N1) Viruses Infection.

Authors:  Ying Qin; Peter W Horby; Tim K Tsang; Enfu Chen; Lidong Gao; Jianming Ou; Tran Hien Nguyen; Tran Nhu Duong; Viktor Gasimov; Luzhao Feng; Peng Wu; Hui Jiang; Xiang Ren; Zhibin Peng; Sa Li; Ming Li; Jiandong Zheng; Shelan Liu; Shixiong Hu; Rongtao Hong; Jeremy J Farrar; Gabriel M Leung; George F Gao; Benjamin J Cowling; Hongjie Yu
Journal:  Clin Infect Dis       Date:  2015-05-04       Impact factor: 9.079

4.  Avian influenza A(H5N1) and A(H9N2) seroprevalence and risk factors for infection among Egyptians: a prospective, controlled seroepidemiological study.

Authors:  Mokhtar R Gomaa; Ahmed S Kayed; Mona A Elabd; Dina Abu Zeid; Shaimaa A Zaki; Amira S El Rifay; Lobna S Sherif; Pamela P McKenzie; Robert G Webster; Richard J Webby; Mohamed A Ali; Ghazi Kayali
Journal:  J Infect Dis       Date:  2014-10-29       Impact factor: 5.226

Review 5.  Continuing challenges in influenza.

Authors:  Robert G Webster; Elena A Govorkova
Journal:  Ann N Y Acad Sci       Date:  2014-05-30       Impact factor: 5.691

6.  Reply to "Studies on influenza virus transmission between ferrets: the public health risks revisited".

Authors:  Marc Lipsitch; Thomas V Inglesby
Journal:  MBio       Date:  2015-01-23       Impact factor: 7.867

7.  Studies on influenza virus transmission between ferrets: the public health risks revisited.

Authors:  Ron A M Fouchier
Journal:  MBio       Date:  2015-01-23       Impact factor: 7.867

8.  Rethinking biosafety in research on potential pandemic pathogens.

Authors:  Marc Lipsitch; Barry R Bloom
Journal:  MBio       Date:  2012-10-09       Impact factor: 7.867

9.  The production and development of H7 Influenza virus pseudotypes for the study of humoral responses against avian viruses.

Authors:  Eleonora Molesti; Giovanni Cattoli; Francesca Ferrara; Eva Böttcher-Friebertshäuser; Calogero Terregino; Nigel Temperton
Journal:  J Mol Genet Med       Date:  2013-02-19

10.  Virulence attenuation during an influenza A/H5N1 pandemic.

Authors:  Maciej F Boni; Tran Dang Nguyen; Menno D de Jong; H Rogier van Doorn
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2013-02-04       Impact factor: 6.237
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.